SLC39A8 and congenital disorder of glycosylation: Such treatment is now envisaged for TMEM165-CDG patients as MnCl2/MnSO4-H2O supplementation was shown to be successful for two patients suffering from another CDG, SLC39A8-CDG (Park et al., 2018).